🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting substances of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Material Elimination

According to the social media company, the service has taken down violative material and banned associated keywords and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

After moments of joining one community, a seller posted contact information, where most transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, posts display dark colored parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to potentially significant health risks”.